Biofrontera
BFRI
10 hedge funds and large institutions have $1.45M invested in Biofrontera in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 4 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
23% more capital invested
Capital invested by funds: $1.18M → $1.45M (+$268K)
4.94% more ownership
Funds ownership: 16.69% → 21.62% (+4.9%)
17% less funds holding
Funds holding: 12 → 10 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$232K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$169K |
| 3 |
HF
HRT Financial
New York
|
+$8.45K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$8.08K |
| 5 |
VF
Virtu Financial
New York
|
+$2.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$22.6K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$9K |
| 3 |
JP Morgan Chase
New York
|
-$158 |
| 4 |
Morgan Stanley
New York
|
-$128 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$5 |
BFRI Hedge Fund Activity: Q2 2025 in Review
10 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q2 2025, worth a combined $1.45M — up 23% from $1.18M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BFRI and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 6 added.
The largest buyer was Rosalind Advisors, adding an estimated $232K. The largest seller was Citadel Advisors, exiting entirely with an estimated $22.6K sold.
- 10 institutional investors held Biofrontera (BFRI) as of Q2 2025, down from 12 in Q1 2025.
- Funds reported $1.45M of Biofrontera stock for Q2 2025, up 23% quarter-over-quarter.
- 2 funds opened new Biofrontera positions in Q2 2025 and 4 closed out, a net change of -2 holders.
- The largest Biofrontera buyer in Q2 2025 was Rosalind Advisors, an estimated $232K added.
- The largest Biofrontera seller in Q2 2025 was Citadel Advisors, an estimated $22.6K sold.
Based on aggregated 13F filings for Q2 2025.